藥品參考
Sulfinpyrazone
Sulfinpyrazone is a medicine in the class genitourinary. It is used for gout.
- 藥物類別: Genitourinary
- 用途: gout
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Genitourinary
- 常見劑型
- 錠劑, 膠囊
- 常見規格
- 100 mg, 200 mg
- 商品名
- 2
- 國家與市場
- 1
用途
作用方式
Sulfinpyrazone competitively inhibit the urate anion transporter (URAT1) responsible for reabsorption of uric acid in the proximal tubule. it increase urate excretion in urine and reduce the concentration in plasma.
成人常用劑量（仿單摘要）
200 to 400 mg orally given in 2 equally divided doses, with meals or milk, gradually increasing when necessary to full maintenance dosage in 1 week.
懷孕與哺乳
- 懷孕
- Unknown Discontinued uricosuric for gout. No human pregnancy data; not teratogenic in animals. It inhibits platelet function, so bleeding around delivery is possible. UK label: use with caution, weighing risk against benefit. Uric-acid-lowering drugs are usually stopped until after pregnancy.
- 哺乳
- Unknown Not known if it passes into milk; no LactMed record. UK label: mothers should refrain from taking it, for safety reasons (no data). A uricosuric with antiplatelet action; no infant data. Avoid while breastfeeding; prefer a better-studied option chosen with the prescriber.
已通報的副作用
- Nausea
- Difficulty breathing
- Heartburn
- Upset Stomach
哪些人需要特別留意
- Avoid administering sulfinpyrazone to patients with active peptic ulcer or symptoms of GI inflammation or ulceration or patients with blood dyscrasias.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
同類別的其他藥品
常見問題
What is Sulfinpyrazone used for?
Sulfinpyrazone is a medicine in the class genitourinary. It is used for Gout, Gouty arthritis.
What side effects have been reported with Sulfinpyrazone?
Nausea, Difficulty breathing, Heartburn, Upset Stomach.
Can Sulfinpyrazone be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Discontinued uricosuric for gout. No human pregnancy data; not teratogenic in animals. It inhibits platelet function, so bleeding around delivery is possible. UK label: use with caution, weighing risk against benefit. Uric-acid-lowering drugs are usually stopped until after pregnancy. Breastfeeding: Unknown. Not known if it passes into milk; no LactMed record. UK label: mothers should refrain from taking it, for safety reasons (no data). A uricosuric with antiplatelet action; no infant data. Avoid while breastfeeding; prefer a better-studied option chosen with the prescriber.
What does Sulfinpyrazone interact with?
MediHelp does not list a checked interaction for Sulfinpyrazone yet. Always tell your pharmacist about every medicine you take.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
